Generic name: acebutolol, atenolol, betaxolol, bisoprolol, carteolol, carvedilol, labetalol, metoprolol, nadolol, oxprenolol, penbutolol, pindolol, propranolol, sotalol, tenolol, timolol
Common brand names: Betapace, Blocadren, Cartrol, Coreg, Corgard Inderal, Inderal LA, Kerlone, Levatol, Lopressor, Normodyne, Sectral, Tenormin, Toprol-XL, Trandate, Visken, Zebeta, Zelate
General categories: Antiadrenergic, antianginal agents, antianxiety therapy adjunct, antiarrhythmic agents, antiglaucoma agent, antihypertensive agents, antitremor agent, beta-adrenoceptor blockers, beta-blockers, hypertrophic cardiomyopathy therapy adjunct, myocardial infarction prophylactic, myocardial infarction therapy, neuroleptic-induced akathisia therapy, pheochromocytoma therapy adjunct, thyrotoxicosis therapy adjunct, vascular headache prophylactic
Numerous studies suggest that beta-blockers can reduce mortality by 25% to 40% in patients with certain kinds of heart failure, and cut sudden cardiac death up to 50% in patients with a recent heart attack. One study in the October 29, 2002 issue of Circulation found that those taking beta-blockers had 15% to 38% less risk of dying compared with those not taking these drugs. The death rates for beta-blocker patients were 16% at two years and 34% at five years, significantly lower than the death rates of 27% at two years and 50% at five years for patients not receiving beta-blockers. Beta-blocker therapy, however, did not significantly decrease the risk of cardiac arrest or death from heartbeat irregularities of the people in this study, though there was a trend toward this type of benefit.
Another study in the May 1, 2002 issue of the Journal of the American Medical Association looked at close to 630,000 people undergoing coronary artery bypass surgery and found that using beta-blockers before surgery significantly helped to increase survival when compared to not using beta-blockers before the heart surgery.
Do not take the following with beta-blockers except on medical advice:
The following should be considered if you are taking beta-blockers:
Common side effects:
Less common side effects:
Rare side effects:
Secondary prevention includes 1) identifying and treating people with established disease and those at very high risk of developing cardiovascular disease, and 2) treating and rehabilitating people who have had a heart attack or stroke to prevent another cardiovascular or cerebrovascular event.
The American Heart Association recommends the following uses for beta-blockers as secondary prevention:
Take only the amount of beta-blocker ordered by your doctor.
American Heart Association
US Food and Drug Administration
Beta-blockers (Systemic): US Pharmacopeia (USP-DI). Available at: http://www.usp.org/. Accessed December 20, 2002
Komaroff AL. Harvard Medical School Family Health Guide. New York, NY: Simon & Schuster; 1999.
Texas Heart Institute. Available at: http://www.tmc.edu/thi/index.html. Accessed December 23, 2002.
Last reviewed October 2007 by Craig Clark, DO, FACC, FAHA, FASE
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.